The Quarterly Report did have some key lines that sound promising
Blood test for breast cancer should be clinically available in 2024
Laboratory expected to be commissioned and operational in early May 2023
BCAL is continuing to meet with and assess potential partners in the US to further the commercialisation of
the BCAL test and take the test to the US market.
- Forums
- ASX - By Stock
- BDX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
Featured News
Add BDX (ASX) to my watchlist
|
|||||
Last
15.0¢ |
Change
0.010(7.14%) |
Mkt cap ! $47.14M |
Open | High | Low | Value | Volume |
14.0¢ | 15.0¢ | 14.0¢ | $79.68K | 550.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 75000 | 14.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 262480 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 75000 | 0.145 |
1 | 200000 | 0.140 |
6 | 305677 | 0.135 |
4 | 177884 | 0.130 |
3 | 79393 | 0.125 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 262480 | 3 |
0.165 | 123123 | 1 |
0.200 | 100000 | 1 |
0.210 | 10800 | 2 |
0.000 | 0 | 0 |
Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
Featured News
BDX (ASX) Chart |